poisar

Stocks · News reference

Shield Therapeutics Reports Q3 2026 Trading Update

Fiscal.ai

Shield Therapeutics announced its Q3 2026 financial results, reporting group net revenue of $11.5 million and providing updates on its US commercial operations.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    Western Digital vs. Seagate: Best AI Stock to Buy After Earnings

    Both Western Digital and Seagate reported strong Q1 2027 earnings driven by AI infrastructure demand, with revenue growth of 55% and 61% respectively. However, Seagate appears more attractive with a higher ROE of 386.9% versus Western Digital's 57.9%, and a lower forward P/E ratio of 19.01 compared to 19.37, making it the better buy.

  2. Zacks Investment ResearchNa

    Stock Market News for Oct 29, 2026

    U.S. stock markets rose on Wednesday as the Federal Reserve kept interest rates unchanged at 3.75-4% and strong third-quarter earnings boosted investor confidence. The Dow Jones, Nasdaq Composite, and S&P 500 all ended in positive territory. Notable earnings beats from Seagate Technology, Amphenol Corp., and Labcorp Holdings drove their stock prices higher by 4.5%, 3.5%, and 8.8% respectively.